• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    ConsumerDirect Expands Executive Team with Appointment of Gary Lu, CPA as Chief Financial Officer

    5/19/26 9:00:00 AM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Get the next $BMRA alert in real time by email

    Veteran finance and operations leader brings more than 20 years of experience across public companies and high-growth organizations

    ConsumerDirect Inc., an industry leader in helping consumers manage their credit, money, and privacy, today announced the appointment of Gary Lu, CPA as Chief Financial Officer. Mr. Lu brings more than two decades of financial, accounting, and operational leadership across public companies, high-growth fintech, and Fortune 500 enterprises.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519292056/en/

    Gary Lu, Chief Financial Officer

    Gary Lu, Chief Financial Officer

    In his role as Chief Financial Officer, Mr. Lu will oversee the company's financial operations, including cash and revenue management, forecasting, financial reporting, and regulatory compliance. He will partner closely with the executive team and Board of Directors on strategic planning, financial analysis, and key growth initiatives, supporting data‑driven decision‑making and the continued scaling of the company's subscription‑based business.

    "We are thrilled to welcome Gary to the ConsumerDirect team at such a pivotal time for our business," said David B. Coulter, CEO of ConsumerDirect. "Gary brings a proven track record of financial leadership, operational rigor, and strategic insight that will be essential to our team as we continue to grow and scale. His deep expertise and disciplined approach to driving growth and efficiency make him the ideal partner to help guide our next phase."

    Mr. Lu most recently served as Chief Financial Officer of Biomerica, Inc. (NASDAQ:BMRA), where he oversaw finance, accounting, tax, treasury, investor relations, legal, HR, and IT. His experience includes leading capital markets transactions, complex SEC reporting, SOX compliance, M&A integrations, and enterprise system implementations. Prior to Biomerica, he held a senior finance role at Happy Money, a consumer fintech he helped scale through rapid growth. He began his career at Ernst & Young, where he led financial statement audits and SOX implementations for Fortune 500 clients.

    Mr. Lu's leadership has been recognized through his 2025 Orange County Business Journal Public Company CFO of the Year nomination and his selection as a 2025 LA Times Studios CFO Executive of the Year finalist, highlighting his impact in both corporate leadership and community service. He is a graduate of the University of California, Los Angeles, with a Bachelor of Arts in Economics and a minor in Accounting.

    "I am excited to join ConsumerDirect at such an important moment in its growth journey," said Mr. Lu. "The company has built a strong foundation and clear vision for the future. I look forward to partnering with David and the leadership team to further strengthen and scale the company, while also advocating for more consumers to better their financial health."

    Beyond his corporate role, Mr. Lu is passionate about giving back to his local community. He is the founder of Forge Optima, a 501(c)(3) nonprofit that partners with schools and communities to help students discover their identity, purpose, and pathways before life's biggest decisions are made. Mr. Lu also serves on the University of California, Irvine Paul Merage School of Business Master of Finance Industry Advisory Board and on the Executive Board of the American Cancer Society, Orange County, continuing his commitment to advancing causes that impact education and health.

    To learn more about ConsumerDirect and its offerings, please visit www.consumerdirect.com.

    About ConsumerDirect, Inc.

    Founded in 2003, ConsumerDirect, Inc. is a subscription-based consumer fintech platform operating at the intersection of credit, financial intelligence, and privacy protection. ConsumerDirect delivers personalized, data-driven financial insights and services directly to consumers through a vertically integrated platform, supported by both direct-to-consumer and partner distribution channels. Unlike traditional SaaS or software models, ConsumerDirect is built on persistent one-to-one relationships with consumers and partners, positioning the Company as a consumer financial platform rather than a replaceable enterprise software provider.

    ConsumerDirect, Inc. has 23 granted and issued patents covering its unique technologies and designs, along with 14 registered trademarks covering its various products and features. More about ConsumerDirect can be found at ConsumerDirect. Additionally, ConsumerDirect's primary consumer subscriber product is at SmartCredit.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260519292056/en/

    Media Contact

    Natasha Koleas

    Consumerdirect@icrinc.com

    Get the next $BMRA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BMRA

    DatePrice TargetRatingAnalyst
    5/5/2026$9.00Mkt Outperform
    Citizens
    More analyst ratings

    $BMRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Chin Eric was granted 22,500 shares, increasing direct ownership by 225% to 32,500 units (SEC Form 4)

    4 - BIOMERICA INC (0000073290) (Issuer)

    1/28/26 5:40:25 PM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Chief Financial Officer Lu Gary was granted 40,000 shares, increasing direct ownership by 206% to 59,375 units (SEC Form 4)

    4 - BIOMERICA INC (0000073290) (Issuer)

    12/31/25 5:10:08 PM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Executive Vice-Chairman Barbieri Allen was granted 30,000 shares, increasing direct ownership by 127% to 53,543 units (SEC Form 4)

    4 - BIOMERICA INC (0000073290) (Issuer)

    12/31/25 5:10:05 PM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $BMRA
    SEC Filings

    View All

    Biomerica Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - BIOMERICA INC (0000073290) (Filer)

    6/4/26 4:45:41 PM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form 10-Q filed by Biomerica Inc.

    10-Q - BIOMERICA INC (0000073290) (Filer)

    4/13/26 5:15:20 PM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form S-8 filed by Biomerica Inc.

    S-8 - BIOMERICA INC (0000073290) (Filer)

    2/27/26 5:15:26 PM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $BMRA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development

    IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:BMRA), a developer and manufacturer of diagnostic test systems and CDMO services provider, today announced it has entered into a Master Services Agreement (MSA) with a confidential life sciences company to develop proprietary in vitro diagnostic (IVD) assays. The engagement carries an initial contract development target fee of over $1.75 million, to be earned across multiple Statements of Work (SOWs) under the MSA. Biomerica was chosen following a competitive evaluation in which multiple CDMO organizations were assessed. The MSA establishes an initial three-year term with automatic one-year renewals. All developm

    5/28/26 8:19:00 AM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    ConsumerDirect Expands Executive Team with Appointment of Gary Lu, CPA as Chief Financial Officer

    Veteran finance and operations leader brings more than 20 years of experience across public companies and high-growth organizations ConsumerDirect Inc., an industry leader in helping consumers manage their credit, money, and privacy, today announced the appointment of Gary Lu, CPA as Chief Financial Officer. Mr. Lu brings more than two decades of financial, accounting, and operational leadership across public companies, high-growth fintech, and Fortune 500 enterprises. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519292056/en/Gary Lu, Chief Financial Officer In his role as Chief Financial Officer, Mr. Lu will oversee the

    5/19/26 9:00:00 AM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Biomerica's inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026

    IRVINE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:BMRA), a global biomedical technology company focused on innovative diagnostic-guided therapies, today announced that an abstract evaluating the real-world clinical effectiveness of its inFoods® IBS diagnostic-guided therapy has been accepted for poster presentation at Digestive Disease Week® (DDW) 2026, to be held May 2–5, 2026, at McCormick Place in Chicago, Illinois. DDW is the world's largest gathering of physicians, researchers, and industry professionals in gastroenterology, hepatology, and related GI disciplines. Acceptance of this poster reflects the growing interest within the gastroenterology community in

    4/29/26 8:19:00 AM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $BMRA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citizens initiated coverage on Biomerica with a new price target

    Citizens initiated coverage of Biomerica with a rating of Mkt Outperform and set a new price target of $9.00

    5/5/26 7:04:01 AM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $BMRA
    Leadership Updates

    Live Leadership Updates

    View All

    ConsumerDirect Expands Executive Team with Appointment of Gary Lu, CPA as Chief Financial Officer

    Veteran finance and operations leader brings more than 20 years of experience across public companies and high-growth organizations ConsumerDirect Inc., an industry leader in helping consumers manage their credit, money, and privacy, today announced the appointment of Gary Lu, CPA as Chief Financial Officer. Mr. Lu brings more than two decades of financial, accounting, and operational leadership across public companies, high-growth fintech, and Fortune 500 enterprises. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519292056/en/Gary Lu, Chief Financial Officer In his role as Chief Financial Officer, Mr. Lu will oversee the

    5/19/26 9:00:00 AM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

    Brings decades of leadership in laboratory testing, clinical diagnostics, payor strategy, and sales growth Extensive track record in commercializing advanced laboratory testing and insurer strategies IRVINE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ:BMRA), a global provider of advanced diagnostic solutions, today announced the appointment of Gary Huff to its Board of Directors as an independent board member. Mr. Huff brings decades of leadership experience in the diagnostics and healthcare services industry, including serving as Chief Executive Officer of LabCorp Diagnostics, one of the world's largest clinical laboratories. Mr. Huff is a hands-on, inspirational,

    10/8/25 8:19:00 AM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer

    Brings 20+ years of revenue growth leadership in laboratory testing, clinical diagnostics and global expansionLed successful organizational turnarounds and growth strategies at both Boston Heart Diagnostics and Genova DiagnosticsExtensive track record in commercializing advanced laboratory testing, driving growth and payer strategies IRVINE, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ:BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment of Scott Madel as Chief Commercial Officer. Scott brings more than two decades of cross-functional expertise in healthcare, diagnostics, commercialization, and pa

    6/26/25 8:19:00 AM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $BMRA
    Financials

    Live finance-specific insights

    View All

    Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022

    InFoods® IBS Data Receives American College of Gastroenterology Presidential Award (ACG) Following Presentation at Annual Scientific Meeting  Trial Data Shows InFoods® IBS Treatment Diet Significantly Improved Several IBS Symptoms Including Abdominal Pain Intensity (API): In Some Cases Better Than Certain Currently Marketed Drugs  Launch of InFoods® IBS Lab Developed Test Expected in Fiscal 3Q  Amazon Now Fulfills Sales of Aware® Breast Self Exam and EZ Detect™ Colon Disease Tests IRVINE, Calif., Jan. 13, 2023 (GLOBE NEWSWIRE) -- IRVINE, CABiomerica, Inc. (NASDAQ:BMRA), (the "Company") a global provider of advanced medical products, today reported its second quarter fiscal 2023 fina

    1/13/23 6:39:00 PM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $BMRA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Biomerica Inc.

    SC 13G/A - BIOMERICA INC (0000073290) (Subject)

    11/14/24 4:19:51 PM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form SC 13G/A filed by Biomerica Inc. (Amendment)

    SC 13G/A - BIOMERICA INC (0000073290) (Subject)

    2/14/24 9:00:06 AM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form SC 13G filed by Biomerica Inc.

    SC 13G - BIOMERICA INC (0000073290) (Subject)

    2/9/24 3:06:57 PM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care